Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0380-0.0020 (-5.00%)
At close: 11:04AM AEDT

Anatara Lifesciences Ltd

62 Lygon Street
Level 3
Carlton, VIC 3053
Australia
61 3 9824 5454
https://anataralifesciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. David Lionel Brookes FACRRM, FAICD, MBBSExec. Chairman118.82kN/A1960
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.Chief Operations OfficerN/AN/AN/A
Jane LoweManaging Director of IR DepartmentN/AN/AN/A
Mr. Simon ErskineChief Devel. OfficerN/AN/AN/A
Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICDCompany Sec.N/AN/AN/A
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing ManagementCommercial Mang.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Corporate governance

Anatara Lifesciences Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.